ocular cancer

ocular cancer is a rare and diverse group of diseases that affect the eye and surrounding tissues, including the orbit, adnexa, and optic nerve. Ocular cancer can be primary, originating in the eye, or secondary, metastasizing from other parts of the body, such as the breast, lung, or skin. According to the National Cancer Institute, American Cancer Society, and World Health Organization, ocular cancer accounts for a small percentage of all cancer cases, with retinoblastoma being the most common primary ocular cancer in children. Researchers at the University of California, Los Angeles, Harvard University, and Johns Hopkins University have made significant contributions to the understanding of ocular cancer.

Types of ocular cancer

Ocular cancer encompasses various types, including retinoblastoma, uveal melanoma, lymphoma, and squamous cell carcinoma. Retinoblastoma is a malignant tumor that originates in the retina and is most commonly diagnosed in children under the age of 5 years, as reported by the Centers for Disease Control and Prevention and St. Jude Children's Research Hospital. Uveal melanoma is the most common primary ocular cancer in adults, affecting the uvea, which includes the iris, ciliary body, and choroid, according to the American Academy of Ophthalmology and National Eye Institute. Lymphoma can also affect the eye and is often associated with Hodgkin lymphoma or non-Hodgkin lymphoma, as studied by researchers at the University of Chicago and Stanford University. Other types of ocular cancer include medulloepithelioma, adenocarcinoma, and sarcoma, which have been investigated by scientists at the Massachusetts Institute of Technology and University of Oxford.

Causes and risk factors

The exact causes of ocular cancer are not fully understood, but several risk factors have been identified, including genetic mutations, exposure to ultraviolet radiation, and immune system disorders. Genetic mutations in the RB1 gene can increase the risk of developing retinoblastoma, as discovered by researchers at the University of Pennsylvania and Columbia University. Exposure to ultraviolet radiation from the sun or tanning beds can increase the risk of developing uveal melanoma, according to the Skin Cancer Foundation and American Academy of Dermatology. Immune system disorders, such as HIV/AIDS, can also increase the risk of developing ocular cancer, as reported by the Centers for Disease Control and Prevention and World Health Organization. Other risk factors include family history, previous cancer diagnosis, and exposure to certain chemicals, which have been studied by scientists at the University of California, Berkeley and Yale University.

Symptoms and diagnosis

The symptoms of ocular cancer can vary depending on the type and location of the tumor, but common symptoms include vision loss, eye pain, and eye redness. Vision loss can occur suddenly or gradually, and may be accompanied by floaters or flashes of light, as described by patients at the Bascom Palmer Eye Institute and Wills Eye Hospital. Eye pain and eye redness can be caused by inflammation or irritation of the eye and surrounding tissues, according to the American Academy of Ophthalmology and National Eye Institute. Diagnosis of ocular cancer typically involves a combination of imaging tests, such as computed tomography and magnetic resonance imaging, and biopsy, which have been developed by researchers at the University of California, San Francisco and Duke University. Fluorescein angiography and ultrasound biomicroscopy can also be used to diagnose and monitor ocular cancer, as used by clinicians at the Massachusetts Eye and Ear Infirmary and University of Washington.

Treatment

Treatment of ocular cancer depends on the type, size, and location of the tumor, as well as the overall health of the patient, and may involve surgery, radiation therapy, and chemotherapy. Surgery can be used to remove the tumor and surrounding tissues, and may involve enucleation or exenteration, as performed by surgeons at the Memorial Sloan Kettering Cancer Center and University of Texas MD Anderson Cancer Center. Radiation therapy can be used to shrink the tumor and reduce symptoms, and may involve external beam radiation therapy or brachytherapy, according to the American Society for Radiation Oncology and National Cancer Institute. Chemotherapy can be used to treat ocular cancer that has spread to other parts of the body, and may involve systemic chemotherapy or intra-arterial chemotherapy, as developed by researchers at the University of Michigan and University of Southern California.

Prognosis

The prognosis for ocular cancer varies depending on the type and stage of the disease, as well as the effectiveness of treatment, and can be influenced by factors such as tumor size, tumor location, and patient age. Retinoblastoma has a high cure rate if diagnosed and treated early, with a 5-year survival rate of over 90%, according to the National Cancer Institute and American Cancer Society. Uveal melanoma has a poorer prognosis, with a 5-year survival rate of around 50%, as reported by the American Academy of Ophthalmology and National Eye Institute. Lymphoma and other types of ocular cancer have variable prognoses, depending on the specific type and stage of the disease, which have been studied by researchers at the University of California, Los Angeles and Harvard University.

Epidemiology

Ocular cancer is a rare disease, accounting for only a small percentage of all cancer cases, with an estimated incidence rate of around 6 cases per million people per year, according to the National Cancer Institute and Centers for Disease Control and Prevention. Retinoblastoma is the most common primary ocular cancer in children, with an estimated incidence rate of around 11 cases per million children per year, as reported by the American Academy of Pediatrics and St. Jude Children's Research Hospital. Uveal melanoma is the most common primary ocular cancer in adults, with an estimated incidence rate of around 4 cases per million adults per year, according to the American Academy of Ophthalmology and National Eye Institute. Researchers at the University of Oxford and University of Cambridge are working to improve our understanding of the epidemiology of ocular cancer. Category:Ocular cancer